Methylphenidate for treating tobacco dependence in non-attention deficit hyperactivity disorder smokers: A pilot randomized placebo-controlled trial

BACKGROUND: Methylphenidate blocks the re-uptake of dopamine by binding to the dopamine transporter in the presynaptic cell membrane and increases extracellular dopamine levels. Similarities in neuropsychologic effects between nicotine and methylphenidate make it an intriguing potential therapeutic...

Descripción completa

Detalles Bibliográficos
Autores principales: Hurt, Richard D, Ebbert, Jon O, Croghan, Ivana T, Schroeder, Darrell R, Sood, Amit, Hays, J Taylor
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3038986/
https://www.ncbi.nlm.nih.gov/pubmed/21276244
http://dx.doi.org/10.1186/1477-5751-10-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3038986/
https://www.ncbi.nlm.nih.gov/pubmed/21276244
http://dx.doi.org/10.1186/1477-5751-10-1

Ejemplares similares